Preparation method of human umbilical cord blood stem cell composition convenient for gastrointestinal absorption

The preparation method using a combination of small molecule peptides and complex enzyme fermentation bacteria solves the problems of low absorption rate and decreased bioactivity of orally administered stem cells in the gastrointestinal tract, improves the absorption rate and survival rate of stem cells, enhances the therapeutic effect, and improves the taste and immunity of the product.

CN118987167AInactive Publication Date: 2024-11-22ZHONGTIAN DEHENG (NANJING) MEDICAL FOOD CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411119514.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In existing technologies, the absorption rate of orally administered stem cells in the gastrointestinal tract is low, and gastric acid and digestive enzymes can damage stem cells, leading to a decrease in biological activity and making it difficult to achieve an effective therapeutic dose.

Method used

Small molecule peptides (SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3) are used to protect stem cells, and a combination of compound enzymes and compound fermentation bacteria is used to enhance the stress resistance and bioactivity of stem cells. Combined with a multifunctional induced stem cell line, a human umbilical cord blood stem cell composition that is easily absorbed by the gastrointestinal tract is prepared.

Benefits of technology

It significantly improves the absorption rate and survival rate of stem cells in the gastrointestinal tract, maintains high bioactivity, enhances therapeutic effects, and improves the taste and sensory quality of the product. It also has the potential to enhance immunity and promote bone tissue regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987167A_ABST
    Figure CN118987167A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biomedicine, in particular to a preparation method of a human umbilical cord blood stem cell composition convenient for gastrointestinal absorption. The stem cells are effectively protected from being damaged by gastric acid and enzyme by using the small molecule peptide, optimization is carried out aiming at the problem that the biological activity of the stem cells absorbed by oral administration can be obviously reduced, and the stress resistance and activity of the stem cells are obviously enhanced by double means of gene modification and polypeptide protection, so that the survival rate of the stem cells in vivo is improved, and the stem cells are effectively protected. The stem cells can still keep relatively high biological activity after being absorbed by gastrointestinal tracts, so that the treatment effect of the stem cells is enhanced; chromatographic analysis shows that the composition adopting the compound enzyme and the compound zymophyte is more uniform in molecular weight distribution, the proportion of low-molecular-weight protein hydrolysate is higher, and the yield is greatly improved; the bitter taste of the composition adopting the compound enzyme and the compound zymophyte is obviously reduced, the sensory quality is obviously improved, and the composition is more suitable for oral application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to a method for preparing a human umbilical cord blood stem cell composition that is easy to absorb by the gastrointestinal tract. Background Art

[0002] Stem cell therapy has great potential in regenerative medicine and disease treatment; however, traditional stem cell therapy mainly relies on invasive methods, such as intravenous injection or local injection, which limits its large-scale application. In order to achieve a more convenient treatment method, researchers have begun to explore stem cell preparations that can be absorbed through the gastrointestinal tract in recent years to achieve more convenient oral treatment.

[0003] Existing research and data show that the gastrointestinal absorption efficiency of traditional oral preparations is low, only about 10-20%, mainly due to the destructive effect of gastric acid and digestive enzymes on stem cells; however, the absorption rate can be increased to more than 30% through coating technology or adding protective peptides;

[0004] In addition, the biological activity of orally absorbed stem cells often decreases significantly. Although studies have attempted to improve the stress resistance and activity of stem cells through genetic modification, the effect still needs to be optimized. The survival rate of modified stem cells in the body has only increased by about 50%; the clinical effect is limited. In the mouse model, oral stem cells show a certain effect on gastrointestinal damage repair, but the repair efficiency is only increased by about 40%; although the existing scheme has made certain progress in improving the absorption rate and biological activity of oral stem cells, it still needs further optimization; therefore, there is an urgent need for a method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption to solve such problems. Summary of the invention

[0005] To this end, the present invention provides a method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption, so as to overcome the problems in the prior art that the absorption rate of oral stem cells in the gastrointestinal tract is low, it is difficult to achieve an effective therapeutic dose, and gastric acid and digestive enzymes will destroy the stem cells, resulting in a decrease in their biological activity.

[0006] To achieve the above object, the present invention provides a method for preparing a human umbilical cord blood stem cell composition that is easy to absorb in the gastrointestinal tract, comprising:

[0007] The stem cell composition comprises the following components:

[0008] (i) the polypeptide of SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or a sequence having at least 70% homology to the polypeptide sequence thereof;

[0009] or (ii) a polynucleotide sequence encoding a polypeptide of SEQ ID NO.1, SEQ ID NO.2, or SEQ ID NO.3, or a sequence having at least 85% homology to the nucleotide sequence thereof;

[0010] The polypeptide is a small molecule peptide: SEQ ID NO.1: SFHRLHLWKALKK, SEQ ID NO.2: VEIPHSFHVEDD, SEQ ID NO.3: FFGVRKKPWKLAK.

[0011] Furthermore, the stem cell composition also includes a pluripotent induced stem cell line.

[0012] Furthermore, the pluripotent induced stem cell line is derived from mesenchymal stem cells.

[0013] Furthermore, the polypeptide preparation method is:

[0014] Step S1, chopping antler into base fiber powder;

[0015] Step S2, extracting the compatible polymer carrier with ethanol at room temperature, filtering, and concentrating with a water bath and a rotary vacuum evaporator;

[0016] Step S3, mixing the concentrated solution with a hydrolase for reaction;

[0017] Step S4, treating the filtered and concentrated material with fermentation bacteria;

[0018] Step S5, ultrafiltration treatment is performed on the concentrated fermentation liquid, and freeze-drying is performed after obtaining the active extract;

[0019] Step S6, detecting the extracted product in step S5 by reverse phase high performance liquid chromatography, and sequencing the polypeptide.

[0020] Furthermore, in step S3, the mass ratio of the hydrolytic enzymes in the enzymatic hydrolysis stage is 10-25 parts of pepsin and 5-10 parts of α-chymotrypsin.

[0021] Furthermore, in step S4, the fermentation bacteria are yeast and lactic acid bacteria in a mass ratio of 1-5:5-10.

[0022] Furthermore, in step S5, the concentrated ultrafiltration treatment is carried out at room temperature, 2,500 mL of 75% concentration Ethanol solution is mixed with the powder at a dilution ratio of 1:5 (W / V), and extracted within 24 hours, filtered using a ceramic membrane with a molecular weight cutoff of 1 kDa, and then concentrated using a rotary vacuum evaporator in a water bath at 40°C.

[0023] Furthermore, in step S5, the active extract subjected to ultrafiltration treatment is a fraction smaller than 1-2 kDa.

[0024] Furthermore, step S6 uses a C18 column and acetonitrile as the mobile phase, and the concentrations of acetonitrile in the two mobile phases are 10% and 90%, respectively.

[0025] Furthermore, in step S6, the sample volume is 2500 μL, the flow rate is 30 mL / min, the detection wavelength is 210 nm, the elution peaks are observed, and the elution peaks are subjected to mass spectrometry analysis respectively.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] The present invention uses small molecule peptides (SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3) to effectively protect stem cells from being damaged by gastric acid and enzymes, thereby significantly improving the absorption rate.

[0028] The present invention optimizes the problem that the biological activity of orally absorbed stem cells will be significantly reduced, and even after genetic modification, the survival rate of stem cells in the body is limited. Through the dual means of genetic modification and polypeptide protection, the stress resistance and activity of stem cells are significantly enhanced, the survival rate of stem cells in the body is improved, and the stem cells can still maintain a high biological activity after being absorbed through the gastrointestinal tract, thereby enhancing their therapeutic effect.

[0029] The present invention, through chromatographic analysis, shows that the composition using the composite enzyme and the composite fermentation bacteria has a more uniform molecular weight distribution, and the proportion of low molecular weight protein hydrolysate (less than 1000u) is higher, and the yield is greatly improved; the bitterness of the composition using the composite enzyme and the composite fermentation bacteria is significantly reduced, and the sensory quality is significantly improved; the preparation method provided by the present invention not only improves the yield of the product, but also improves the taste of the product, making it more suitable for oral application.

[0030] The stem cell composition prepared by the method provided in the present invention has the effect of enhancing immunity, especially in improving the activity of antioxidant enzymes.

[0031] The small molecule peptide provided in the present invention can significantly promote the proliferation of osteoblasts, and the effect is enhanced with the increase of dosage, and is most significant at a concentration of 2 μmol / L; the stem cell composition has certain potential in promoting bone tissue regeneration.

[0032] The invention solves the problems in the prior art that the absorption rate of oral stem cells in the gastrointestinal tract is low, it is difficult to reach an effective therapeutic dose, and gastric acid and digestive enzymes will destroy the stem cells, resulting in a decrease in their biological activity. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 The figure is a schematic diagram of the polypeptide preparation process of the human umbilical cord blood stem cell composition of the present invention. DETAILED DESCRIPTION

[0034] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0035] It should be noted that the terms "first", "second", etc. in the specification and claims of the present invention and the above-mentioned drawings are used to distinguish similar objects, and are not necessarily used to describe a specific order or sequence. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the present invention described herein can be implemented in an order other than those illustrated or described herein. In addition, the terms "including" and "having" and any variations thereof are intended to cover non-exclusive inclusions, for example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units that are clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.

[0036] The present invention is further described in detail below in conjunction with the accompanying drawings:

[0037] Example 1

[0038] The stem cell composition comprises: a multifunctional induced stem cell line and a polypeptide in a mass ratio of 1:1;

[0039] To generate pluripotent induced stem cell lines:

[0040] The herbal sample used in the experiment was Gan Mo; 100 grams of dried Gan Mo herbal sample was put into one liter of water, and water was extracted by ultrasonic extraction equipment for 16 hours, and then filtered through filter paper; the filtrate was concentrated in a rotary vacuum evaporator and then freeze-dried; then, a Jeju persimmon extract with a concentration of 1-1000 μg / ml and 0.1 v / v% of energy water were added to prepare a reversal medium;

[0041] The herbal sample Gan Mo is an active ingredient contained in the reversal medium composition of the present invention, which is a perennial seaweed of the Laminariaceae family, mainly a food source for abalone and turban shells, and is also used as a main raw material for making alginate, iodine, potassium or food;

[0042] The persimmon extract contained in the present invention can be water, (a) anhydrous or aqueous lower alcohol (methanol, ethanol, propanol, butanol, n-propanol, isopropanol and n-butanol, etc.) lower alcohol and water, (b) a solvent mixed with lower alcohol and water, (c) acetone, (d) ethyl acetate, (e) chloroform, (f) 1,3-butanediol, (g) hexane, (h) diethyl ether, etc., preferably a solvent mixed with methanol or ethanol and water;

[0043] When a mixed solvent is used for extraction, the content of methanol or ethanol is preferably 50-80 v / v%;

[0044] First, the umbilical cord tissue is removed and the matrix of the umbilical cord is separated from the blood vessels and other internal parts; after removing the blood vessels, the separated tissue is cut into small pieces (0.5cm x 0.5cm) for cell extraction;

[0045] Pluripotent stem cells were prepared from human mesenchymal stem cells according to the concentration of persimmon extract in the reversal medium;

[0046] Human umbilical cord stem cells were induced to transform into pluripotent stem cells by using a reversal medium. Studies have shown that when the concentration of persimmon extract in the reversal medium is between 1 and 400 μg / ml, a colony formation effect can be observed in the medium.

[0047] The colony was treated with 1 mg / ml collagenase, and then the colony cells were isolated; the colony cells were seeded into DMEM / F12 medium containing 10% FBS, 100 units / ml penicillin and 50 μg / ml streptomycin, and cultured in a CO2 incubator; the medium was replaced every 2 to 3 days; when the cells reached about 80%, they were subcultured, and a stem cell line was established after two subcultures;

[0048] The method for preparing the polypeptide is as follows:

[0049] Step S1, chopping the antler into base fiber powder; the dosage of the antler powder is 500g;

[0050] Step S2, extracting the compatible polymer carrier with ethanol at room temperature and filtering it, and then concentrating it with a water bath and a rotary vacuum evaporator;

[0051] Step S3, then mixing the concentrated solution with a hydrolase for reaction;

[0052] Step S4, treating the filtered and concentrated material with fermentation bacteria;

[0053] Step S5, finally, ultrafiltration treatment is performed on the concentrated fermentation liquid, and freeze-drying is performed after obtaining the active extract;

[0054] Step S6, detecting the product extracted in step S5 by reverse phase high performance liquid chromatography, and sequencing the polypeptide; the mass ratio of the hydrolase is 10 parts of pepsin and 5 parts of α-chymotrypsin;

[0055] Concentration ultrafiltration was performed at room temperature. 2,500 mL of 75% Ethanol solution was mixed with the powder at a dilution ratio of 1:5 (W / V), and extracted within 24 hours. The mixture was filtered using a ceramic membrane with a molecular weight cutoff of 1 kDa, and then concentrated using a rotary vacuum evaporator in a water bath at 40°C. The fermentation bacteria were yeast and lactic acid bacteria in a mass ratio of 1:5.

[0056] Step S6 uses a C18 column and acetonitrile as a mobile phase, the concentrations of acetonitrile in the two mobile phases are 10% and 90%, respectively; the sample volume is 2500 μL, the flow rate is 30 mL / min, the detection wavelength is 210 nm, the elution peaks are observed, and the elution peaks are respectively subjected to mass spectrometry analysis;

[0057] Step S5: ultrafiltration treatment of the active extract to obtain a fraction less than 1 kDa.

[0058] Example 2

[0059] The stem cell composition comprises: a multifunctional induced stem cell line and a polypeptide in a mass ratio of 2:1;

[0060] Preparation of induced pluripotent stem cell lines:

[0061] The herbal sample used in the experiment was from Gan Mo; 100 grams of dried Gan Mo herbal sample was put into one liter of water, and water was extracted by ultrasonic extraction equipment for 16 hours, and then filtered through filter paper; the filtrate was concentrated in a rotary vacuum evaporator and then freeze-dried; then a Jeju persimmon extract with a concentration of 1-1000 μg / ml and 0.1 v / v% of energy water were added to prepare a reversal medium;

[0062] The persimmon extract contained in the present invention can be prepared by using water, (a) anhydrous or aqueous lower alcohol (methanol, ethanol, propanol, butanol, n-propanol, isopropanol and n-butanol, etc.) lower alcohol and water, (b) a solvent mixed with lower alcohol and water, (c) acetone, (d) ethyl acetate, (e) chloroform, (f) 1,3-butanediol, (g) hexane, (h) diethyl ether, etc., preferably a solvent mixed with methanol or ethanol and water; when a mixed solvent is used for extraction, the content of methanol or ethanol is preferably 50-80 v / v%;

[0063] First, the umbilical cord tissue was removed and the matrix of the umbilical cord was separated from the blood vessels and other internal parts; after removing the blood vessels, the separated tissue was cut into small pieces (0.5cm x 0.5cm) for cell extraction;

[0064] According to the concentration of dried persimmon extract in the reversal medium, pluripotent stem cells are prepared from human mesenchymal stem cells; human umbilical cord stem cells are induced according to the reversal medium to transform the stem cells into pluripotent stem cells;

[0065] The colonies were treated with 1 mg / ml collagenase, and then the colony cells were isolated; the colony cells were seeded into DMEM / F12 medium containing 10% FBS, 100 units / ml penicillin and 50 μg / ml streptomycin, and cultured in a CO2 incubator; the medium was replaced every 2 to 3 days; when the cells reached about 80%, they were subcultured, and a stem cell line was established after two subcultures;

[0066] The method for preparing the polypeptide is as follows:

[0067] Step S1, chopping the antler into base fiber powder; the dosage of the antler powder is 500g

[0068] Step S2, extracting the compatible polymer carrier with ethanol at room temperature and filtering it, and then concentrating it with a water bath and a rotary vacuum evaporator;

[0069] Step S3, mixing the concentrated solution with a hydrolase for reaction;

[0070] Step S4, treating the filtered and concentrated material with fermentation bacteria;

[0071] Step S5, ultrafiltration treatment is performed on the concentrated fermentation liquid, and freeze-drying is performed after obtaining the active extract;

[0072] Step S6, detecting the product extracted in step S5 by reverse phase high performance liquid chromatography, and sequencing the polypeptide; the mass ratio of the hydrolase is 25 parts of pepsin and 10 parts of α-chymotrypsin;

[0073] Concentration ultrafiltration was performed at room temperature. 2,500 mL of 75% Ethanol solution was mixed with the powder at a dilution ratio of 1:5 (W / V) and extracted within 24 hours. The mixture was filtered using a ceramic membrane with a molecular weight cutoff of 1 kDa and then concentrated using a rotary vacuum evaporator in a water bath at 40°C.

[0074] The fermentation bacteria mass ratio is 5:10 of yeast and lactic acid bacteria; step S6 uses a C18 column and acetonitrile as the mobile phase, and the concentrations of acetonitrile in the two mobile phases are 10% and 90%, respectively; the sample volume is 2500 μL, the flow rate is 30 mL / min, the detection wavelength is 210 nm, the elution peak is observed, and the elution peak is subjected to mass spectrometry analysis respectively; step (5) ultrafiltration treatment of the active extract is a fraction less than 2 kDa.

[0075] Example 3

[0076] The original protein peptide in step S5 of Example 1 was used and the elution peaks were respectively subjected to mass spectrometry analysis, and the active peptide sequence of the small molecule was determined and selected by high performance liquid chromatography-mass spectrometry technology; the water solubility, antigenicity and other physicochemical properties of the peptide were predicted by the online databases AllerTOPv.2.0 and Innovagen; the toxicology and safety properties were predicted by the online database ADMETLab2.0; and the unreported peptides with the function of inducing the expression of immune factor activity were screened out by the online database BIOPEP-UMW database;

[0077] The polypeptide is a small molecule peptide, and the polypeptide sequence is: SEQ ID NO.1: SFHRLHLWKALKK, SEQ ID NO.2: VEIPHSFHVEDD, SEQ ID NO.3: FFGVRKKPWKLAK.

[0078] Example 4

[0079] The preparation process is the same as that of Example 1, except that a general enzyme preparation is used instead of a composite enzyme.

[0080] Example 5

[0081] The preparation process is the same as that of Example 1, except that general fermentation bacteria are used instead of composite fermentation bacteria.

[0082] Example 6

[0083] The preparation process is the same as that of Example 1, except that the concentrated extract in general step 5 is used instead of the sequenced small molecule peptide.

[0084] Experimental Example 1

[0085] Product molecular weight distribution and product yield determination:

[0086] The products prepared by the methods of Examples 1 to 6 were sampled and analyzed by chromatography. The analysis method was based on the proportion of protein hydrolyzates with a relative molecular mass of less than 1000u (high performance gel filtration chromatography) shown in Appendix A of GB / T22729-2008, and the molecular weight range and number average molecular weight were obtained. The yield was calculated by the output and input amount.

[0087] The final results show that the yield of Example 1-2 using the composite enzyme and composite fermentation bacteria was greatly improved, while the comparative examples 4-5 without the composite enzyme and composite fermentation bacteria produced too much residual unreacted protein, and the loss was large during the impurity removal process, resulting in poor yield;

[0088] Product sensory comparison:

[0089] The products prepared by the methods of Examples 1 to 6 were prepared into a 10% solution by mass, with the bitterness of water being 0,CK, and the bitterness of the 10% solution of spleen peptide obtained by comparison being 10, and 10 professional evaluators were asked to evaluate the bitterness, and the average value was taken after removing the highest and lowest scores;

[0090] The final results show that in Examples 4 and 5 where the production conditions were not adjusted, the bitter taste was more obvious;

[0091] The bitterness of the products using the compatible polymer carrier, composite enzyme, and composite fermentation bacteria of Examples 1 and 2 is significantly reduced;

[0092] Specifically, based on the molecular weight distribution, yield and sensory evaluation of Experimental Example 1, it can be seen that the chromatographic analysis shows that the composition using the composite enzyme and the composite fermentation bacteria is more uniform in molecular weight distribution, and the proportion of low molecular weight protein hydrolysates (less than 1000u) is higher, and the yield is greatly improved; the bitterness of the composition using the composite enzyme and the composite fermentation bacteria is significantly reduced, and the sensory quality is significantly improved; the preparation method provided by the present invention not only improves the yield of the product, but also improves the taste of the product, making it more suitable for oral application.

[0093] Experimental Example 2

[0094] The feeding experiment was conducted using hamsters as research subjects;

[0095] The temperature of the breeding environment is controlled between 22±3℃, and the humidity range is set at 50±20%; at the same time, the light period starts at 6 am and ends at 6 am the next day, and the dark period starts at 6 am the next day and ends at 6 am; each period lasts for 12 hours, and the environmental temperature and humidity are monitored throughout the day;

[0096] During the experiment, five groups of hamsters were cultured, each group containing 10 hamsters; a control group was set up, the control group used CK ordinary protein powder, and the hamsters were given regular mouse feed and fed twice a day; the hamsters in the other groups were fed with the small molecule peptide mass spectrometry sequenced in Example 3; the feeding experiment was carried out for 6 to 8 weeks; during this period, the hamsters had sufficient free drinking water;

[0097] After the experiment, the blood samples of the hamsters were collected and analyzed in detail: anticoagulation was performed with sodium citrate solution, and then the blood samples were centrifuged at 200g; platelets were aggregated to obtain platelet-rich plasma; the platelet-rich plasma was combined with the inducer ADP to observe the aggregation of platelets; the immune status of the hamsters was judged; if the values ​​of SOD and GSH-Px were increased, it means that the hamsters have stronger immunity; the test results of immune cell SODG and SH-Px factor responses are shown in Table 1;

[0098] Table 1: Immune cell SODG and SH-Px factor response test

[0099]

[0100] It can be seen from the data in Table 1 that the hamsters that eat the feed added with the small molecule peptide mass spectrometry sequencing product in Example 3 have higher SOD and GSH-Px enhancement values, and the hamsters have stronger immunity;

[0101] In addition, the bioactive small molecule peptide prepared by the method of Example 3 has significant angiotensin converting enzyme inhibitory activity and can prevent cardiovascular diseases;

[0102] Specifically, Experimental Example 2 monitored the immune indicators of the hamsters raised to verify the effect of adding small molecule peptides to the feed on the hamsters' immunity; the results showed that the immune indicators (SOD and GSH-Px) of the hamsters that ate the feed containing the small molecule peptides in Example 3 were significantly improved, much higher than those of the control group; indicating that the stem cell composition prepared by the method provided by the present invention has the effect of enhancing immunity, especially in improving the activity of antioxidant enzymes.

[0103] Experimental Example 3

[0104] The feeding experiment was conducted using mouse embryonic osteoblast precursor cells as research subjects;

[0105] Mouse embryonic osteoblast precursor cells were seeded in a 96-well plate at 2×104 cells / well; after culturing at 37° C. for 24 hours, a-MEM complete medium containing 0, 0.02, 0.2, and 2 μmol / L of the bioactive small molecule peptide prepared according to the method of Example 3 and IPP was added, respectively, and after culturing at 37° C. for 24 hours, 10 μL of CCK-8 was added to each well under sterile conditions, and the plates were cultured in an incubator for 30 minutes and shaken well; the absorbance was measured at 450 nm using an enzyme marker;

[0106] The conclusion is that small molecule peptides can promote osteoblast proliferation, and the effect increases with the increase of dose, and the proliferation effect is significantly higher than the proliferation effect of IPP on mouse MC3T3-E1; the proliferation rate is highest when the concentration is 2μmol / L.

[0107] Specifically, Experimental Example 3 verified the effect of small molecule peptides in promoting osteoblast proliferation through a culture experiment of mouse embryonic osteoblast precursor cells; the experimental results showed that small molecule peptides can significantly promote the proliferation of osteoblasts, and its effect increases with the increase of dosage, and the proliferation effect is significantly higher than that of the control IPP, especially at a concentration of 2μmol / L.

[0108] In summary, it can be seen that the present invention, by using small molecule peptides (SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3), effectively protects stem cells from damage by gastric acid and enzymes, and significantly improves the absorption rate; the biological activity of orally absorbed stem cells will be significantly reduced, and even through genetic modification, the survival rate of stem cells in the body is limited. This problem is optimized, and the dual means of genetic modification and polypeptide protection are used to significantly enhance the stress resistance and activity of stem cells, so that the survival rate of stem cells in the body is improved, so that the stem cells can still maintain a high biological activity after being absorbed through the gastrointestinal tract, thereby enhancing their therapeutic effect; chromatographic analysis shows that the composition using composite enzymes and composite fermentation bacteria is more uniform in molecular weight distribution, and the proportion of low molecular weight protein hydrolysates (less than 1000u) is higher, and the yield is greatly improved; the use of composite The bitterness of the composition of enzyme and composite fermentation bacteria is significantly reduced, and the sensory quality is significantly improved; the preparation method provided by the present invention not only improves the yield of the product, but also improves the taste of the product, making it more suitable for oral application; the stem cell composition has the effect of enhancing immunity, especially in improving the activity of antioxidant enzymes; small molecule peptides can significantly promote the proliferation of osteoblasts, and the effect increases with the increase of dosage, and is most significant at a concentration of 2 μmol / L; the stem cell composition has certain potential in promoting bone tissue regeneration, and solves the problem in the prior art that the absorption rate of oral stem cells in the gastrointestinal tract is low, it is difficult to reach an effective therapeutic dose, and gastric acid and digestive enzymes will destroy stem cells, resulting in a decrease in their biological activity.

[0109] So far, the technical solutions of the present invention have been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it is easy for those skilled in the art to understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.

Claims

1. A method for preparing a human umbilical cord blood stem cell composition that is easy to absorb in the gastrointestinal tract, It is characterized in that The stem cell composition comprises the following components: (i) the polypeptide of SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3 or a sequence having at least 70% homology to the polypeptide sequence thereof; or (ii) a polynucleotide sequence encoding a polypeptide of SEQ ID NO.1, SEQ ID NO.2, or SEQ ID NO.3, or a sequence having at least 85% homology to the nucleotide sequence thereof; The polypeptide is a small molecule peptide: SEQ ID NO.1: SFHRLHLWKALKK, SEQ ID NO.2: VEIPHSFHVEDD, SEQ ID NO.3: FFGVRKKPWKLAK.

2. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 1, It is characterized in that The stem cell compositions also include induced pluripotent stem cell lines.

3. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 2, It is characterized in that The pluripotent induced stem cell line is derived from mesenchymal stem cells.

4. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 3, It is characterized in that The polypeptide preparation method is: Step S1, chopping antler into base fiber powder; Step S2, extracting the compatible polymer carrier with ethanol at room temperature, filtering, and concentrating with a water bath and a rotary vacuum evaporator; Step S3, mixing the concentrated solution with a hydrolase for reaction; Step S4, treating the filtered and concentrated material with fermentation bacteria; Step S5, ultrafiltration treatment is performed on the concentrated fermentation liquid, and freeze-drying is performed after obtaining the active extract; Step S6, detecting the extracted product in step S5 by reverse phase high performance liquid chromatography, and sequencing the polypeptide.

5. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 4, It is characterized in that In step S3, the mass ratio of hydrolytic enzymes in the enzymatic hydrolysis stage is 10-25 parts of pepsin and 5-10 parts of α-chymotrypsin.

6. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 5, It is characterized in that In step S4, the fermentation bacteria are yeast and lactic acid bacteria in a mass ratio of 1-5:5-10.

7. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 6, It is characterized in that In step S5, the concentrated ultrafiltration treatment is carried out at room temperature. 2,500 mL of 75% concentration Ethanol solution is mixed with the powder at a dilution ratio of 1:5 (W / V), and extracted within 24 hours. The solution is filtered using a ceramic membrane with a molecular weight cutoff of 1 kDa, and then concentrated using a rotary vacuum evaporator in a water bath at 40°C.

8. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 7, It is characterized in that In step S5, the active extract subjected to ultrafiltration treatment is a fraction smaller than 1-2 kDa.

9. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 8, It is characterized in that In step S6, a C18 column is used and acetonitrile is used as the mobile phase. The concentrations of acetonitrile in the two mobile phases are 10% and 90%, respectively.

10. The method for preparing a human umbilical cord blood stem cell composition that is easy for gastrointestinal absorption according to claim 9, It is characterized in that In step S6, the sample volume is 2500 μL, the flow rate is 30 mL / min, the detection wavelength is 210 nm, the elution peaks are observed, and the elution peaks are respectively subjected to mass spectrometry analysis.